BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25185215)

  • 1. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
    Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
    J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
    Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
    Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PARP-1 Deficiency and Histamine H
    Durante M; Sgambellone S; Lanzi C; Nardini P; Pini A; Moroni F; Masini E; Lucarini L
    Front Pharmacol; 2019; 10():525. PubMed ID: 31164820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
    Kseibati MO; Sharawy MH; Salem HA
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
    Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
    J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis.
    Di Paola R; Talero E; Galuppo M; Mazzon E; Bramanti P; Motilva V; Cuzzocrea S
    Respir Res; 2011 Apr; 12(1):41. PubMed ID: 21477302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
    Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
    Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
    Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
    Zhao L; Mu B; Zhou R; Cheng Y; Huang C
    Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis.
    Kida T; Ayabe S; Omori K; Nakamura T; Maehara T; Aritake K; Urade Y; Murata T
    PLoS One; 2016; 11(12):e0167729. PubMed ID: 27992456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
    Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
    BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
    Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
    Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
    Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
    Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride.
    Tawfik MK; Makary S
    Eur J Pharmacol; 2017 Nov; 814():114-123. PubMed ID: 28821451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.